Dhar & Mohanty (2020) suggest that prebiotics and probiotics should be considered as "co-supplementation" along with current therapies to help patients who suffer with the symptoms of Covid-19.
The research group of Settanni et al. (2021) agrees.
In fact, the long term consequences of Covid-19 such as respiratory disturbances, fatigue, and psychological impairments are considered to be inflammatory response that may be due to the gut - lung interaction.
Some of the reasons why a good probiotic and prebiotic supplement will support our health are discussed in length in both articles. For example, Prebiotics are known to increase butyrate levels and hence reducing inflammation and even improving conditions such as asthma and cystic fibrosis (Dhar & Mohanty, 2020; Anand & Mande, 2018). Probiotics have also shown to improve lung conditions by modulating the immune system.
Check out the Original Synbiotic, a broad spectrum probiotic formula with prebiotic.
Suggested use: One teaspoon by mouth (very tasty) or mixed in a little water.
- Di Renzo, L., Merra, G., Esposito, E., & De Lorenzo, A. (2020). Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?. European review for medical and pharmacological sciences, 24(8), 4062-4063. Letter-to-the-Editor
- Dhar, D., & Mohanty, A. (2020). Gut microbiota and Covid-19-possible link and implications. Virus research, 285, 198018. Article
- Settanni, C. R., Ianiro, G., Ponziani, F. R., Bibbò, S., Segal, J. P., Cammarota, G., & Gasbarrini, A. (2021). COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World journal of gastroenterology, 27(43), 7433. Article
- Anand, S., & Mande, S. S. (2018). Diet, microbiota and gut-lung connection. Frontiers in microbiology, 2147. Article
We have developed our products based on scientific research and/or the practical experience of many healthcare practitioners. There is a growing body of literature on food based nutrition and supplements and their application in support of our health. Please use our products under the advisement of your doctor.
Antibiotics and inflammatory disease:
Feng, Y., Huang, Y., Wang, Y., Wang, P., Song, H., & Wang, F. (2019). Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy. PloS one, 14(6), e0218384. Article
©2005 - 2022 BioImmersion Inc. All Rights Reserved